ZA962526B - Synthetic hpv6/11 hybrid l1 dna encoding human papillomavirus type 11 l1 protein - Google Patents

Synthetic hpv6/11 hybrid l1 dna encoding human papillomavirus type 11 l1 protein

Info

Publication number
ZA962526B
ZA962526B ZA962526A ZA962526A ZA962526B ZA 962526 B ZA962526 B ZA 962526B ZA 962526 A ZA962526 A ZA 962526A ZA 962526 A ZA962526 A ZA 962526A ZA 962526 B ZA962526 B ZA 962526B
Authority
ZA
South Africa
Prior art keywords
protein
human papillomavirus
synthetic
hpv6
hybrid
Prior art date
Application number
ZA962526A
Other languages
English (en)
Inventor
Kathryn J Hofmann
Kathrin U Jansen
Michael P Neeper
Joseph G Joyce
Hugh A George
E Dale Lehman
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27022236&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA962526(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of ZA962526B publication Critical patent/ZA962526B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
ZA962526A 1995-03-30 1996-03-29 Synthetic hpv6/11 hybrid l1 dna encoding human papillomavirus type 11 l1 protein ZA962526B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41357295A 1995-03-30 1995-03-30
US41357195A 1995-03-30 1995-03-30

Publications (1)

Publication Number Publication Date
ZA962526B true ZA962526B (en) 1996-09-04

Family

ID=27022236

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA962526A ZA962526B (en) 1995-03-30 1996-03-29 Synthetic hpv6/11 hybrid l1 dna encoding human papillomavirus type 11 l1 protein

Country Status (21)

Country Link
US (1) US6159729A (no)
EP (1) EP0817852B1 (no)
JP (1) JP3918877B2 (no)
KR (1) KR100441477B1 (no)
CN (1) CN1154732C (no)
AT (1) ATE247712T1 (no)
AU (1) AU708111B2 (no)
CZ (1) CZ291375B6 (no)
DE (1) DE69629556T2 (no)
DK (1) DK0817852T3 (no)
EA (1) EA000969B1 (no)
ES (1) ES2203691T3 (no)
HU (1) HU228490B1 (no)
IL (1) IL117591A0 (no)
NO (1) NO320086B1 (no)
NZ (1) NZ306663A (no)
PL (1) PL183299B1 (no)
PT (1) PT817852E (no)
SK (1) SK283998B6 (no)
WO (1) WO1996030520A2 (no)
ZA (1) ZA962526B (no)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0782615A4 (en) * 1994-09-22 2001-08-22 Merck & Co Inc DNA ENCODING FOR HUMAN PAPILLOMAVIRUS TYPE 6A
GB9621091D0 (en) 1996-10-09 1996-11-27 Fondation Pour Le Perfectionem Attenuated microorganisms strains and their uses
EE9900612A (et) * 1997-04-08 2000-08-15 Merck & Co., Inc. Inimese papilloomiviiruse stabiliseeritud preparaadid
CN1354787A (zh) * 1998-08-14 2002-06-19 麦克公司 纯化人乳头瘤病毒样颗粒的方法
DE19840263C1 (de) * 1998-09-03 2000-05-25 Deutsches Krebsforsch Papillomviren, Mittel zu deren Nachweis sowie zur Therapie von durch sie verursachten Erkrankungen
US6380364B1 (en) 1998-11-23 2002-04-30 Loyola University Of Chicago Chimeric biotin-binding papillomavirus protein
AUPP765398A0 (en) 1998-12-11 1999-01-14 University Of Queensland, The Treatment of papillomavirus infections
SI1150712T1 (sl) 1999-02-05 2009-02-28 Merck & Co Inc Pripravek cepiva proti humanem papiloma virusu
US7001995B1 (en) * 1999-08-25 2006-02-21 Merck & Co., Inc. Synthetic human papillomavirus genes
SI1421200T1 (sl) * 2001-08-23 2007-04-30 Merck & Co Inc Poskusi PCR fluorescentnih multipleks HPV-jev z uporabo vec fluoroforov
EP1302550A1 (en) * 2001-10-10 2003-04-16 King Car Food Industrial Co., Ltd. Method and detector for identifying subtypes of human papilloma viruses
US20040223976A1 (en) * 2003-03-07 2004-11-11 Elisabetta Bianchi Influenza virus vaccine
ES2381964T3 (es) 2003-03-24 2012-06-04 Merck Sharp & Dohme Corp. Expresión optimizada de L1 de VPH 31 en levadura
IL156670A0 (en) * 2003-06-26 2004-01-04 Zvi Zolotariov Aloe suppositories
CA2539703C (en) * 2003-09-25 2011-06-07 Third Wave Technologies, Inc. Detection of human papilloma virus (hpv) utilizing invasive cleavage structure assays
MY140664A (en) * 2003-09-29 2010-01-15 Merck Sharp & Dohme Optimized expression of hpv 45 l1 in yeast
MY139500A (en) * 2003-11-12 2009-10-30 Merck Sharp & Dohme Optimized expression of hpv 58 l1 in yeast
CA2560487C (en) * 2004-03-24 2013-01-29 Merck & Co., Inc. Optimized expression of hpv 52 l1 in yeast
JP5020825B2 (ja) * 2004-12-08 2012-09-05 ジェン−プローブ・インコーポレーテッド 複数型のヒトパピローマウイルスに由来する核酸の検出
CN101341257B (zh) * 2004-12-10 2012-10-10 杰纳罗生物系统有限责任公司 使用核酸探针、微珠和荧光激活的细胞分选器(facs)检测人乳头状瘤病毒(hpv)
PL1844164T3 (pl) * 2005-11-15 2010-12-31 Genoid Kft Sposób wykrywania patogenów z zastosowaniem sond typu "latarni molekularnych"
US8080643B2 (en) * 2006-09-05 2011-12-20 Third Wave Technologies, Inc. HPV primers
CN101200696B (zh) * 2007-11-14 2011-07-20 山东大学 人乳头瘤病毒的酵母增殖模型及建立方法与应用
KR20090073987A (ko) * 2007-12-31 2009-07-03 정운원 인간유두종바이러스 유전자형 검사를 위한 프라이머, 프로브 및 이를 포함하는 ｄｎａ칩, 이의 검사 방법 및 검사 키트
US9376727B2 (en) 2010-05-25 2016-06-28 Qiagen Gaithersburg, Inc. Fast results hybrid capture assay and associated strategically truncated probes
EP2638058B1 (en) 2010-11-12 2017-01-11 Merck Sharp & Dohme Corp. Enolase peptide conjugate vaccines against staphylococcus aureus
EP2722389B1 (en) * 2011-06-15 2018-03-07 Hong Jin Kim Method for enhancing the production yield of human papillomavirus l1 protein
KR20180084139A (ko) 2015-12-04 2018-07-24 시아먼 유니버시티 11형 인유두종 바이러스 엘1 단백질의 돌연변이체
CN110950935A (zh) * 2018-09-26 2020-04-03 厦门大学 一种人乳头瘤病毒51型l1蛋白的突变体

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE122007000017I1 (de) * 1991-07-19 2007-07-26 Univ Queensland Impfstoffe gegen Papillomavirus
EP1588713B1 (en) * 1993-03-09 2010-12-22 The University Of Rochester Production of human papillomavirus HBV-11 capsid protein L1 and virus-like particles

Also Published As

Publication number Publication date
CZ291375B6 (cs) 2003-02-12
EA000969B1 (ru) 2000-08-28
EP0817852A2 (en) 1998-01-14
CZ309197A3 (cs) 1998-02-18
PL322588A1 (en) 1998-02-02
NO974514L (no) 1997-11-27
NZ306663A (en) 1999-10-28
HUP9801608A2 (hu) 1998-10-28
SK129397A3 (en) 1998-05-06
KR19980703391A (ko) 1998-10-15
KR100441477B1 (ko) 2004-10-06
SK283998B6 (sk) 2004-07-07
CN1154732C (zh) 2004-06-23
PT817852E (pt) 2003-12-31
ES2203691T3 (es) 2004-04-16
PL183299B1 (pl) 2002-06-28
WO1996030520A3 (en) 1996-11-07
CN1185810A (zh) 1998-06-24
DE69629556T2 (de) 2004-06-17
AU5527796A (en) 1996-10-16
ATE247712T1 (de) 2003-09-15
DK0817852T3 (da) 2003-11-24
WO1996030520A2 (en) 1996-10-03
IL117591A0 (en) 1996-07-23
JPH11503313A (ja) 1999-03-26
HUP9801608A3 (en) 1999-04-28
JP3918877B2 (ja) 2007-05-23
US6159729A (en) 2000-12-12
EA199700281A1 (ru) 1998-04-30
AU708111B2 (en) 1999-07-29
EP0817852B1 (en) 2003-08-20
HU228490B1 (en) 2013-03-28
NO974514D0 (no) 1997-09-29
NO320086B1 (no) 2005-10-24
DE69629556D1 (de) 2003-09-25

Similar Documents

Publication Publication Date Title
ZA962526B (en) Synthetic hpv6/11 hybrid l1 dna encoding human papillomavirus type 11 l1 protein
BG100974A (en) Vaccines against papillomavirus
HUP9801639A3 (en) Genetic sequences and proteins related to alzheimer's disease, and uses therefor
NZ306009A (en) Medical database system, unique identifier assigned to files, machine readable version of identifier included in hard copies
NL300271I1 (nl) DNA dat humaan papillomavirus type 18 codeert.
GB2302329B (en) Yeast strains
EP0982988A4 (en) IN KEY PURE ZONULIN AS A PHYSIOLOGICAL MODULATOR OF "TIGHT JUNCTIONS" IN MAMMALS
SG54339A1 (en) Novel crystal form of anhydrous 7-(1alpha,salpha, 6alpha,]-6-amino-3-azabicyclo [3.1.0]hex-3-yl)-6-fluoro-1-(2,4-difluorophenyl) (pls refer to file for full detail)
AU8974298A (en) 1,4,7,10-tetraazabicyclo{8.2.2}tetradecan-2-one, a process for the preparation thereof and the use thereof for the preparation of tetraazamacrocycles
IL122606A (en) (S)-hydroxa-nitrile-lyase
CA2200582A1 (en) Dna encoding human papillomavirus type 6a
TW261532B (no)
MX9707457A (es) Acido desoxirribonucleico sintetico hibrido l1 de hpv6/11 que codifica proteina l1 de virus de papiloma humano tipo 11.
CA2216827A1 (en) Synthetic hpv6/11 hybrid l1 dna encoding human papillomavirus type 11 l1 protein
DE59702821D1 (en) Dimethyl-substituierte cyclohexandienderivate
ATE328088T1 (de) Transketolase-verwandtes protein